Skip to content

Tdx(R) Amylase Ii

by Abbott Laboratories 510(k)

Active United States

510(k) K863622

Overview

The TDX AMYLASE II is a device used for catalytic methods to measure amylase levels in clinical chemistry testing. It is designed for use in laboratory settings to quantify amylase activity in patient samples.

The device is supplied as a Class II medical device with special controls, cleared by the FDA under 510(k) number K863622 on October 3, 1986. It is manufactured by Abbott Laboratories and is intended for single-use in clinical chemistry laboratories. The device is regulated under 862.1070 and is not indicated for MRI safety.

AI-generated from registry data, 6 Oct 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK863622 Date3 Oct 1986ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls: none on record (FDA, checked 22 Oct 2026)

Specification

510(k)

510(k) Number
FDA Product Code
JFJ
Device Class
Class II
Regulation
21 CFR Part 862.1070
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Other devices from Abbott Laboratories

See all devices from Abbott Laboratories →

Questions

  • What is the TDX AMYLASE II used for?

    The TDX AMYLASE II is a device designed for catalytic methods to measure amylase levels in clinical chemistry testing. It is intended for use in laboratory settings to quantify amylase activity in patient samples.

  • Is the TDX AMYLASE II a single-use device?

    Yes, the TDX AMYLASE II is intended for single-use in clinical chemistry laboratories. It is not designed for reuse and should be discarded after one use to ensure accurate test results and maintain safety standards.

  • What is the regulatory status of the TDX AMYLASE II?

    The TDX AMYLASE II is a Class II medical device with special controls, cleared by the FDA under 510(k) number K863622 on October 3, 1986. It is regulated under 862.1070 and is not indicated for MRI safety.

  • Who manufactures the TDX AMYLASE II?

    The TDX AMYLASE II is manufactured by Abbott Laboratories, a company headquartered at One Abbott Park Rd., Abbott Park, IL 60064. The device is part of their clinical chemistry testing product line.